Comparison of cardiovascular disease risk assessment tools in primary prevention patients with raised lipoprotein(a)

Back

ESC Professional Premium Access

Comparison of cardiovascular disease risk assessment tools in primary prevention patients with raised lipoprotein(a)

Session: Lipids as risk factors for cardiovascular disease

Topic: Scores

Speaker: Doctor H. Carlton (Chichester, GB)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Henry Charles Carlton

Western Sussex Hospitals NHS Foundation Trust, Chichester (United Kingdom of Great Britain & Northern Ireland)

0 follower

8 more presentations in this session

Physician disagreement with treatment guidelines as a critical barrier to achieving low-density lipoprotein cholesterol targets in very high-risk patients: an implementation science study

Speaker: Associate Professor K. Cho (Gwangju, KR)

Lipoprotein(a) and atherosclerotic cardiovascular disease in a Brazilian tertiary hospital population

Speaker: Doctor V. Zorzanelli Rocha (Sao Paulo, BR)

Impact of glucose metabolism status on the relationship between remnant cholesterol and ischemic risk after percutaneous coronary intervention: a large-scale long-term cohort study from real-world

Speaker: Doctor K. Yan (Beijing, CN)

Association between lipoprotein particle concentration and size and progression of coronary plaque: the MACS Longitudinal Coronary CT angiography study

Speaker: Doctor R. Quispe (Baltimore, US)

The association of inflammation, triglycerides and lipoprotein(a) with cardiovascular events in the UK Biobank

Speaker: Doctor B. Tucker (Sydney, AU)

Access the full session

Lipids as risk factors for cardiovascular disease

Speakers: Doctor H. Carlton, Associate Professor K. Cho, Doctor V. Zorzanelli Rocha, Doctor K. Yan, Doctor R. Quispe...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources